Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferences
Glanzmann thrombasthenia
Print
Other Resources UpToDate PubMed

Glanzmann thrombasthenia

Print Images (1)
Contributors: Nina Haghi MD, Paritosh Prasad MD
Other Resources UpToDate PubMed

Alerts and Notices

Synopsis

Glanzmann thrombasthenia : Bleeding time prolonged, Fibrinogen decreased, Ecchymosis, Epistaxis, Gingival hemorrhage, Menorrhagia
Glanzmann thrombasthenia (GT) is an autosomal dominant coagulation disorder that results in spontaneous, prolonged, or heavy bleeding that can be life-threatening. It is caused by mutations in the ITGA2B or ITGB3 gene that result in defective or deficient platelet alpha IIb beta 3 integrin (formerly known as glycoprotein llb/llla), which is the platelet fibrinogen receptor. The functionality of this receptor is necessary for platelet aggregation. Acquired GT, on the other hand, is due to autoantibodies against alpha IIb beta 3 integrin.

Signs and symptoms include manifestations of mucocutaneous bleeding such as epistaxis, menorrhagia, petechiae, easy bruising, hematoma, and rarely intracranial hemorrhage or hematuria. Family history of bleeding is common.

Codes

ICD10CM:
D69.1 – Qualitative platelet defects

SNOMEDCT:
32942005 – Glanzmann Thrombasthenia

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed:02/01/2021
Last Updated:01/16/2022
Copyright © 2023 VisualDx®. All rights reserved.
Glanzmann thrombasthenia
Print  
A medical illustration showing key findings of Glanzmann thrombasthenia : Bleeding time prolonged, Fibrinogen decreased, Ecchymosis, Epistaxis, Gingival hemorrhage, Menorrhagia
Copyright © 2023 VisualDx®. All rights reserved.